A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Related studies linked through entity extraction aliases.